Intellipharmaceutics International Inc.
IPCIQ
$0.00
$0.000.00%
OTC PK
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -3,392.05% | 84.79% | 59.33% | -195.51% | 64.79% |
| Total Depreciation and Amortization | 0.25% | -0.25% | -38.11% | 27.38% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | 101.43% | -- | -- |
| Total Other Non-Cash Items | 168.60% | -250.88% | -97.74% | 36,178.57% | 99.71% |
| Change in Net Operating Assets | 1,624.15% | -58.36% | 137.02% | 358.69% | -105.08% |
| Cash from Operations | 168.45% | 731.69% | 92.75% | 33.16% | 13.44% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 168.45% | 731.69% | -446.34% | 101.40% | -281.60% |